CRO

Enteris gets into contract manufacturing with new plant

Enteris BioPharma is looking to make some money on the side of its drug-delivery operation, opening a contract manufacturing facility and scouting for clients. The company has set aside space in its 32,000-square-foot plant in Boonton, NJ, for commercial API production, a move CEO Brian Zietsman said "is an important milestone for Enteris as we seek to fully maximize the assets and expertise that we acquired when the company was launched in 2013." More